A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Cited by (1,095)

Items 601–700 of 1,095

1. Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness
   Vanja Đurić, Sarah Clayton, Mai Lan Leong, Li‐Lian Yuan · 2016 · Neural Plasticity
2. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
   Francisca Charliane Carlos da Silva, Maria do Carmo de Oliveira Citó, Maria Izabel Gomès Silva, Brinell Arcanjo Moura, Manuel Rufino de Aquino Neto, Mariana Lima Feitosa, Raquell de Castro Chaves, Danielle S. Macêdo, Silvânia Maria Mendes Vasconcelos, Marta Maria de França Fonteles et al. · 2010 · Brain Research Bulletin
3. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence
   Norman Sartorius, Thomas C. Baghai, David S. Baldwin, Barbara M Barrett, Ursula Brand, Wolfgang Fleischhacker, Guy M. Goodwin, Heinz Grunze, Martin Richard John Knapp, Brian E. Leonard et al. · 2007 · The International Journal of Neuropsychopharmacology
4. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway
   Satoshi Deyama, Yuka Ishikawa, Kotomi Yoshikawa, Kento Shimoda, Soichiro Ide, Masamichi Satoh, Masabumi Minami · 2017 · The International Journal of Neuropsychopharmacology
5. From synapse to nucleus: Novel targets for treating depression
   Covington, Herbert E., Vialou, Vincent, Nestler, Eric J. · 2010 · Neuropharmacology
6. Sex-Dependent Effects of Stress on Immobility Behavior and VTA Dopamine Neuron Activity: Modulation by Ketamine
   Rincón-Cortés, Millie, Grace, Anthony A. · 2017 · International Journal of Neuropsychopharmacology
7. MAPK signaling correlates with the antidepressant effects of ketamine.
   G. Z. Réus, Flavio Geraldo Vieira, H. M. Abelaira, Monique Michels, D. B. Tomaz, M. A. D. dos Santos, A. S. Carlessi, Morgana V. Neotti, Beatriz I. Matias, J. R. Luz et al. · 2014 · Journal of Psychiatric Research
8. Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
   Brittany A. Jaso, Mark J. Niciu, Nicolas D. Iadarola, Níall Lally, Erica M. Richards, Minkyung Park, Elizabeth D. Ballard, Allison Carol Nugent, Rodrigo Machado‐Vieira, Carlos A. Zarate · 2016 · Current Neuropharmacology
9. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
   Morteza Jafarinia, Mohsen Afarideh, Abbas Tafakhori, Mohammad Arbabi, Alireza Ghajar, Ahmad Ali Noorbala, Maryam Alamdar Saravi, Elmira Agah, Shahin Akhondzadeh · 2016 · Journal of Affective Disorders
10. Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study
    Paul Glue, Shona Neehoff, Amandine J. M. Sabadel, Lucy Charlotte Broughton, Martin Le Nedelec, Shabah M. Shadli, Neil McNaughton, Natalie J. Medlicott · 2019 · Journal of Psychopharmacology
11. Randomized trial of ketamine masked by surgical anesthesia in patients with depression
    Theresa Riki Lii, Ashleigh E. Smith, Josephine R. Flohr, Robin L. Okada, Cynthia A. Nyongesa, Lisa J. Cianfichi, Laura M. Hack, Alan F. Schatzberg, Boris Dov Heifets · 2023 · Nature Mental Health
12. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
    Fortunato, Jucélia J., Réus, Gislaine Z., Kirsch, Tamires R., Stringari, Roberto B., Fries, Gabriel R., Kapczinski, Flávio, Hallak, Jaime E., Zuardi, Antônio W., Crippa, José A., Quevedo, João · 2010 · Journal of Neural Transmission
13. Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases
    Robert H. Paul, Nadine Schaaff, Frank Padberg, Hans‐Jürgen Möller, Thomas Frodl · 2008 · The World Journal of Biological Psychiatry
14. Sensorimotor modulation of mood and depression: An integrative review
    Resit S. Canbeyli · 2009 · Behavioural Brain Research
15. Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression
    Rohan, Michael L., Yamamoto, Rinah T., Ravichandran, Caitlin T., Cayetano, Kenroy R., Morales, Oscar G., Olson, David P., Vitaliano, Gordana, Paul, Steven M., Cohen, Bruce M. · 2014 · Biological Psychiatry
16. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
    Mathai, David S., Meyer, Matthew J., Storch, Eric A., Kosten, Thomas R. · 2020 · Journal of Affective Disorders
17. Gestational and lactational exposure to bisphenol-A affects anxiety- and depression-like behaviors in mice
    Xiaohong Xu, Xing Hong, Lingdan Xie, Tao Li, Yujie Yang, Qin Zhang, Guangxia Zhang, Xingyi Liu · 2012 · Hormones and Behavior
18. The Neuropsychology of Anxiety
    Neil McNaughton, J.A. Gray · 2024
19. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
    Farley, Severine, Apazoglou, Kalliopi, Witkin, Jeffrey M., Giros, Bruno, Tzavara, Eleni T. · 2010 · The International Journal of Neuropsychopharmacology
20. Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test
    Paul J. Fitzgerald, Jessica Y. Yen, Brendon O. Watson · 2019 · PLoS ONE
21. Absence of long‐term analgesic effect from a short‐term S‐ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo‐controlled trial
    Ingeborg M. Noppers, Marieke Niesters, Maarten Swartjes, Martin Bauer, Leon P.H.J. Aarts, Natasja Geleijnse, René A. G. Mooren, Albert Dahan, Elise Y. Sarton · 2011 · European Journal of Pain
22. Altered Prefrontal Glutamate–Glutamine–γ-Aminobutyric Acid Levels and Relation to Low Cognitive Performance and Depressive Symptoms in Type 1 Diabetes Mellitus
    In Kyoon Lyoo, Sujung J. Yoon, Gail Musen, Donald C. Simonson, Katie Weinger, Nicolas R. Bolo, Christopher M. Ryan, Jieun E. Kim, Perry Franklin Renshaw, Alan M. Jacobson · 2009 · Archives of General Psychiatry
23. Continuation phase intravenous ketamine in adults with treatment-resistant depression
    Jennifer L. Vande Voort, Robert J. Morgan, Simon Kung, Keith G. Rasmussen, José Antonio Quesada Rico, Brian A. Palmer, Kathryn M. Schak, Susannah J. Tye, Matthew J. Ritter, Mark A. Frye et al. · 2016 · Journal of Affective Disorders
24. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery
    Matthew James Robson, Meagan A. Quinlan, Randy Blakely · 2017 · ACS Chemical Neuroscience
25. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
    Dean, Rebecca L, Hurducas, Claudia, Hawton, Keith, Spyridi, Styliani, Cowen, Philip J, Hollingsworth, Sarah, Marquardt, Tahnee, Barnes, Annabelle, Smith, Rebecca, McShane, Rupert et al. · 2021 · Cochrane Database of Systematic Reviews
26. Developments in the field of antidepressants, where do we go now?
    Francesc Artigas · 2013 · European Neuropsychopharmacology
27. Glutamatergic drive of the dorsal raphe nucleus
    Mariano Soiza‐Reilly, Kathryn G. Commons · 2011 · Journal of Chemical Neuroanatomy
28. Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation
    Maged M. Harraz, R Tyagi, Pedro Cortés, Solomon H. Snyder · 2016 · Molecular Psychiatry
29. Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
    Daniel Miller Rotroff, Daniel G. Corum, Alison A. Motsinger‐Reif, Oliver Fiehn, N Bottrel, Wayne Curtis Drevets, Jaskaran B. Singh, Giacomo Salvadore, Rima Kaddurah‐Daouk · 2016 · Translational Psychiatry
30. Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression
    Ota, Kristie T., Duman, Ronald S. · 2013 · Neurobiology of Disease
31. Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice
    Lee, Younghyurk, Son, Hyeonwi, Kim, Gyeongwha, Kim, Sujeong, Lee, Dong Hoon, Roh, Gu Seob, Kang, Sang Soo, Cho, Gyeong Jae, Choi, Wan Sung, Kim, Hyun Joon · 2013 · Journal of Psychiatry & Neuroscience
32. Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test
    Zomkowski, Andréa D.E., Engel, Daiane, Gabilan, Nelson H., Rodrigues, Ana Lúcia S. · 2010 · European Neuropsychopharmacology
33. Existing and Novel Biological Therapeutics in Suicide Prevention
    Joshua J. Griffiths, Carlos A. Zarate, Joseph J. Rasimas · 2014 · American Journal of Preventive Medicine
34. A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy
    Keith G. Rasmussen, Simon Kung, Maria I. Lapid, Tyler Oesterle, Jennifer R. Geske, Gregory A. Nuttall, William C. Oliver, John P. Abenstein · 2013 · Psychiatry Research
35. Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changes
    Melanie Clarke, Sara Razmjou, Natalie A. Prowse, Zach Dwyer, Darcy Litteljohn, Rowan Pentz, Hymie Anisman, Shawn P. Hayley · 2016 · Neuropharmacology
36. Efficacy of ketamine therapy in the treatment of depression
    Suprio Mandal, VinodKumar Sinha, Nishant Goyal · 2019 · Indian Journal of Psychiatry
37. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression
    Hiroyuki Koike, Kenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki · 2012 · Behavioural Brain Research
38. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
    Matthew James Robson, Meenal Elliott, Michael J. Seminerio, Rae R. Matsumoto · 2011 · European Neuropsychopharmacology
39. Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine’s Rapid Antidepressant Properties
    Duncan, Wallace C., Slonena, Elizabeth, Hejazi, Nadia S., Brutsche, Nancy, Yu, Kevin C., Park, Lawrence, Ballard, Elizabeth D., Zarate, Carlos A. · 2017 · Biological Psychiatry
40. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
    Samuel T. Wilkinson, Rachel B. Katz, Mesut Toprak, Ryan D. Webler, Robert B. Ostroff, Gerard Sanacora · 2018 · The Journal of Clinical Psychiatry
41. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
    Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, Amanda Eskelund, Francisco Silveira Guimarães, Gregers Wegener, Sâmia R.L. Joca · 2019 · Journal of Chemical Neuroanatomy
42. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
    JANUSZ K. RYBAKOWSKI, Agnieszka Permoda‐Osip, Maria Skibińska, R. Adamski, Alicja Bartkowska‐Śniatkowska · 2012 · Human Psychopharmacology Clinical and Experimental
43. Neuroplasticity and the next wave of antidepressant strategies
    Hayley, Shawn, Litteljohn, Darcy · 2013 · Frontiers in Cellular Neuroscience
44. Novel glutamatergic agents for major depressive disorder and bipolar disorder
    Machado-Vieira, Rodrigo, Ibrahim, Lobna, Henter, Ioline D., Zarate, Carlos A. · 2012 · Pharmacology Biochemistry and Behavior
45. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
    Highland, Jaclyn N., Zanos, Panos, Riggs, Lace M., Georgiou, Polymnia, Clark, Sarah M., Morris, Patrick J., Moaddel, Ruin, Thomas, Craig J., Zarate, Carlos A., Pereira, Edna F.R. et al. · 2021 · Pharmacological Reviews
46. (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
    Ago, Yukio, Tanabe, Wataru, Higuchi, Momoko, Tsukada, Shinji, Tanaka, Tatsunori, Yamaguchi, Takumi, Igarashi, Hisato, Yokoyama, Rei, Seiriki, Kaoru, Kasai, Atsushi et al. · 2019 · International Journal of Neuropsychopharmacology
47. Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex
    Jett, Julianne D., Bulin, Sarah E., Hatherall, Lauren C., McCartney, Carlie M., Morilak, David A. · 2017 · Neuroscience
48. Disorders of memory and plasticity in psychiatric disease
    Pittenger, Christopher · 2013 · Dialogues in Clinical Neuroscience
49. Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levels
    Ludka, Fabiana K., Zomkowski, Andréa D.E., Cunha, Mauricio P., Dal-Cim, Tharine, Zeni, Ana Lúcia B., Rodrigues, Ana Lúcia S., Tasca, Carla I. · 2013 · European Neuropsychopharmacology
50. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression
    Ranjbar, Elham, Shams, Jamal, Sabetkasaei, Masoumeh, M-Shirazi, Minoo, Rashidkhani, Bahram, Mostafavi, Ali, Bornak, Eiliyaz, Nasrollahzadeh, Javad · 2014 · Nutritional Neuroscience
51. Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia‐Relevant Deficits
    Bernát Kocsis, Ritchie Edward Brown, Robert W. McCarley, Mihály Hajós · 2013 · CNS Neuroscience & Therapeutics
52. Novel glutamatergic drugs for the treatment of mood disorders
    James W. Murrough, Kyle A. B. Lapidus, Laili Soleimani · 2013 · Neuropsychiatric Disease and Treatment
53. Acute d-serine treatment produces antidepressant-like effects in rodents
    Oz Malkesman, Daniel R. Austin, Tyson R. Tragon, Gang Wang, Gregory R. Rompala, Anahita Hamidi, Zhenzhong Cui, W. Scott Young, Kazu Nakazawa, Carlos A. Zarate et al. · 2011 · The International Journal of Neuropsychopharmacology
54. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies
    Francesc Artigas, Analı́a A Bortolozzi, Pau Celada · 2017 · European Neuropsychopharmacology
55. Depression and antidepressants: molecular and cellular aspects
    Cristina Lanni, Stefano M. Govoni, Adele Lucchelli, Cinzia Boselli · 2009 · Cellular and Molecular Life Sciences
56. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
    Florian Freudenberg, Tansu Celikel, Andreas Reif · 2015 · Neuroscience & Biobehavioral Reviews
57. Individual Stress Vulnerability Is Predicted by Short-Term Memory and AMPA Receptor Subunit Ratio in the Hippocampus
    Schmidt, Mathias V., Trümbach, Dietrich, Weber, Peter, Wagner, Klaus, Scharf, Sebastian H., Liebl, Claudia, Datson, Nicole, Namendorf, Christian, Gerlach, Tamara, Kühne, Claudia et al. · 2010 · The Journal of Neuroscience
58. A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder
    Yin, Honglei, Pantazatos, Spiro P., Galfalvy, Hanga, Huang, Yung‐yu, Rosoklija, Gorazd B., Dwork, Andrew J., Burke, Ainsley, Arango, Victoria, Oquendo, Maria A., Mann, Joseph John · 2016 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
59. Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
    Ionescu, Dawn F., Felicione, Julia M., Gosai, Aishwarya, Cusin, Cristina, Shin, Philip, Shapero, Benjamin G., Deckersbach, Thilo · 2018 · Harvard Review of Psychiatry
60. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
    Yang, Bangkun, Zhang, Ji-chun, Han, Mei, Yao, Wei, Yang, Chun, Ren, Qian, Ma, Min, Chen, Qian-Xue, Hashimoto, Kenji · 2016 · Psychopharmacology
61. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
    Mehdi Ghasemi, Mohsin Raza, Ahmad Reza Dehpour · 2009 · Journal of Psychopharmacology
62. Arketamine, a new rapid-acting antidepressant: A historical review and future directions
    Ji-chun Zhang, Wei Yao, Kenji Hashimoto · 2022 · Neuropharmacology
63. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test
    Bernadeta Szewczyk, Ewa Poleszak, Magdalena Sowa-Kućma, Andrzej Wróbel, S. Słotwiński, Joanna Listos, Piotr Właź, Agnieszka Cichy, Agata Siwek, Małgorzata Dybała et al. · 2009 · Amino Acids
64. An update on the role of glutamate in the pathophysiology of depression
    Mitchell, N. D., Baker, G. B. · 2010 · Acta Psychiatrica Scandinavica
65. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience
    Antonio Tundo, Rocco de Filippis, Luca Proietti · 2015 · World Journal of Psychiatry
66. A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
    Coplan, Jeremy D., Gopinath, Srinath, Abdallah, Chadi G., Berry, Benjamin R. · 2014 · Frontiers in Behavioral Neuroscience
67. The promise of ketamine for treatment‐resistant depression: current evidence and future directions
    Kaitlin E. DeWilde, Cara F. Levitch, James W. Murrough, Sanjay J. Mathew, Dan Vlad Iosifescu · 2015 · Annals of the New York Academy of Sciences
68. Metabotropic glutamate receptors as drug targets: what's new?
    Ferdinando Nicoletti, Valeria Bruno, Richard Teke Ngomba, Roberto Gradini, Giuseppe Battaglia · 2014 · Current Opinion in Pharmacology
69. Neural Plasticity and Proliferation in the Generation of Antidepressant Effects: Hippocampal Implication
    F. Pilar-Cuéllar, R. Vidal, Á. Díaz, E. Castro, S. dos Anjos, Jesús Pascual-Brazo, R. Linge, V. Vargas, H. Blanco, Beatriz Martínez-Villayandre et al. · 2013 · Journal of Neural Transplantation and Plasticity
70. Prophylactic Ketamine Attenuates Learned Fear
    Josephine Cecelia McGowan, Christina T. LaGamma, Sean C. Lim, Melina Tsitsiklis, Yuval Neria, Rebecca A. Brachman, Christine Ann Denny · 2017 · Neuropsychopharmacology
71. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
    Kenichi Fukumoto, Michihiko Iijima, Takeo Funakoshi, Shigeyuki Chaki · 2017 · The International Journal of Neuropsychopharmacology
72. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
    Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, João Quevedo, Martin Walter, Yong‐Ku Kim · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
73. Perspectives for therapy of treatment‐resistant depression
    Mariusz Papp, Wiesław Jerzy Cubała, Łukasz Święcicki, Adrian Newman‐Tancredi, Paul Willner · 2021 · British Journal of Pharmacology
74. The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
    André Schmidt, Michael Kometer, Rosilla F. Bachmann, Erich Seifritz, Franz X. Vollenweider · 2012 · Psychopharmacology
75. Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine’s Antidepressant Response and the Development of Ketamine Addiction
    Udo Bonnet · 2015 · Journal of Psychoactive Drugs
76. Human Biomarkers of Rapid Antidepressant Effects
    Carlos A. Zarate, Daniel C. Mathews, Maura L. Furey · 2013 · Biological Psychiatry
77. Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
    Arabzadeh, Somaye, Hakkikazazi, Elham, Shahmansouri, Nazila, Tafakhori, Abbas, Ghajar, Alireza, Jafarinia, Morteza, Akhondzadeh, Shahin · 2018 · Journal of Affective Disorders
78. Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG
    Zehong Cao, Chin‐Teng Lin, Weiping Ding, Mu‐Hong Chen, Cheng‐Ta Li, Tung‐Ping Su · 2018 · IEEE Transactions on Biomedical Engineering
79. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus
    Burgdorf, J., Zhang, X.-l., Weiss, C., Gross, A., Boikess, S.R., Kroes, R.A., Khan, M.A., Burch, R.M., Rex, C.S., Disterhoft, J.F. et al. · 2015 · Neuroscience
80. Ketamine and other potential glutamate antidepressants
    Arpan Dutta, Shane McKie, J.F.W. Deakin · 2014 · Psychiatry Research
81. Chronic Antidepressant Treatment Impairs the Acquisition of Fear Extinction
    Nesha S. Burghardt, Torfi Sigurdsson, Jack M. Gorman, Bruce S. McEwen, Joseph E. LeDoux · 2012 · Biological Psychiatry
82. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression
    Paul Willner, Piotr Gruca, Magdalena Łasoń, Katarzyna Tota-Glowczyk, Ewa Litwa, Monika Niemczyk, Mariusz Papp · 2018 · Behavioural Pharmacology
83. GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
    Rok Cerne, ARNOLD S. LIPPA, Michael M. Poe, Jodi L. Smith, Xiaoming Jin, Xingjie Ping, Lalit Kumar Golani, James Minton Cook, Jeffrey M. Witkin · 2021 · Pharmacology & Therapeutics
84. Treatment-resistant OCD: Pharmacotherapies in adults
    Peter van Roessel, Giacomo Grassi, Elias N. Aboujaoude, José Manuel Menchón, Michael Van Ameringen, Carolyn I. Rodríguez · 2022 · Comprehensive Psychiatry
85. Mechanisms underlying the antidepressant response and treatment resistance
    Marjorie R. Levinstein, Benjamin A. Samuels · 2014 · Frontiers in Behavioral Neuroscience
86. Ketamine and the Future of Rapid-Acting Antidepressants
    Riggs, Lace M., Gould, Todd D. · 2021 · Annual Review of Clinical Psychology
87. Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine
    Harihar Chilukuri, Narasimha Pothula Reddy, Ram Mohan Pathapati, Arkalgud Nagesha Manu, Sharada Jollu, Ahammad Basha Shaik · 2014 · Indian Journal of Psychological Medicine
88. Targeting glial physiology and glutamate cycling in the treatment of depression
    Gerald W. Valentine, Gerard Sanacora · 2009 · Biochemical Pharmacology
89. Modeling treatment-resistant depression
    Benjamin A. Samuels, E. David Leonardo, Reto A. Gadient, Amanda Williams, Jin Zhou, Denis Joseph Paul David, Alain Michel Gardier, Erik H.F. Wong, René Hen · 2011 · Neuropharmacology
90. Direct Inhibitory Effect of Fluoxetine on N-Methyl-D-Aspartate Receptors in the Central Nervous System
    Bernadett K. Szász, Árpád Mike, Róbert Károly, Zoltán Gerevich, Péter Illés, E. Sylvester Vizi, J. Kiss · 2007 · Biological Psychiatry
91. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice
    Ewa Poleszak, Piotr Właź, Ewa Kędzierska, Dorota Nieoczym, Andrzej Wróbel, Sylwia Fidecka, Andrzej Pilc, Gabriel Nowak · 2007 · Pharmacology Biochemistry and Behavior
92. Biological Mechanisms of Cancer-Induced Depression
    Kimberly Young, Gurmit Singh · 2018 · Frontiers in Psychiatry
93. Psychedelics and Neural Plasticity: Therapeutic Implications
    Grieco, Steven F., Castrén, Eero, Knudsen, Gitte M., Kwan, Alex C., Olson, David E., Zuo, Yi, Holmes, Todd C., Xu, Xiangmin · 2022 · The Journal of Neuroscience
94. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder
    Duncan, Wallace C., Selter, Jessica, Brutsche, Nancy, Sarasso, Simone, Zarate, Carlos A. · 2013 · Journal of Affective Disorders
95. Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications
    Stacey Sedore Willard, Shahriar Koochekpour · 2013 · International Journal of Biological Sciences
96. Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking
    Katherine M. Holleran, Hadley H Wilson, Tracy L. Fetterly, Rebecca J. Bluett, Samuel W. Centanni, Rachel A Gilfarb, Lauren E R Rocco, Sachin Patel, Danny G. Winder · 2016 · Neuropsychopharmacology
97. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression
    Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Mingding Li, Yuping Ning · 2018 · Brain Behavior and Immunity
98. Lack of persistent effects of ketamine in rodent models of depression
    Piotr Popik, Tomasz Kos, Magdalena Sowa-Kućma, Gabriel Nowak · 2008 · Psychopharmacology
99. Opportunities and Challenges of Psychiatric Drug Discovery: Roles for Scientists in Academic, Industry, and Government Settings
    Peter Jeffrey Conn, Bryan L. Roth · 2008 · Neuropsychopharmacology
100. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs
     Joanna Monika Wierońska, Andrzej Pilc · 2009 · Neurochemistry International